Tuesday, March 27, 2012

AstraZeneca (Seroquel) CEO David Brennan sees huge pay jump - HOW CRIME PAYS QUITE HANDSOMELY

AstraZeneca (Seroquel) CEO David Brennan sees pay jump to £9.1m - HOW CORPORATE CRIME PAYS QUITE HANDSOMELY

As countless injured Seroquel litigants are now being pushing & dumped into the streets by unscrupulous ambulance chaser law firms (many of those will cont. to suffer on in abject poverty without ever seeing the slightest shred of justice unto their death); And even after those DOJ (Department of Justice) fines, the massive health damage inflicted upon the general public, the ever growing volumes of documented corp crimes: AstraZeneca Chief David Brennan sees pay jump to £9.1m.

That's right folks, in that other select members only  (TO BIG TO HOLD ACCOUNTABLE) world of corporate crime, pay offs, political wrangling, billion dollar legal teams, and the untold billions in ill gotten profits... CRIME PAYS....& it PAYS OFF BIG TIME


From The Telegraph UK

AstraZeneca chief David Brennan sees pay jump to £9.1m

AstraZeneca chief executive David Brennan saw his total pay climb to more than £9.1m in 2011, after an increased payout from a share award which vested last year.

AstraZeneca chief David Brennan sees pay jump to £9.1m
Mr Brennan's 2008 share award also vested last year, with a value of £5.8m, the annual report shows. Photo: PA
The pay hike happened despite concern about Astra's pipeline of new drugs, as it faces a looming "patent cliff", with several of its best-selling medicines losing exclusivity and facing competition from cheaper generic versions in the next few years.

Last week, the company had to pull the plug on an anti-depressant it was developing, incurring a $50m (£31.3m) charge, and in February announced 7,000 job cuts to save money.

Mr Brennan's base pay rose 2.5pc to £997,223 in 2011, and including a bonus and other payments, was up 11pc to £3.37m, according to the pharma company's annual report.

His 2008 share award also vested last year, with a value of £5.8m, the annual report shows.
The size of the share award was increased by 25pc by the board, after Astra came top of its peer group between 2008 and 2010.

Mr Brennan turned down any increase in his base pay for 2012, the report shows.


  1. Association between Seroquel or quetiapine,and hyperglycemia (diabetes).

    There is concern Seroquel,like other atypical antipsychotic drugs, has the potential to cause metabolic disorders, particularly hyperglycemia (excess sugar) and diabetes. Atypical antipsychotics cause the body to metabolize fat instead of carbohydrates, leading to insulin resistance to the excess carbohydrates. At the same time they promote fat accumulation.I was a patient back in 1996-2000 who was a subject of Eli Lilly's Zyprexa 'viva' Zyprexa' off label sales promotion.I was given it as an ineffective costly treatment for PTSD It gave me diabetes as a side effect.

    Eli Lilly made $65 BILLION on Zyprexa!
    Was called,"the most successful drug in the history of neuroscience".

    Because they PUSHED IT off-label to victims who did not need it.Socked me with thousands in co-pays at $12 per pill.
    Potential conflict of interest.Eli Lilly promotes Zyprexa that will *cause* diabetes and Lilly is also in the business of diabetes treatment.
    --Daniel Haszard

    FMI http://www.zyprexa-victims.com

  2. Petition: Tell the VA and DoD to Ban the Drug Seroquel and Investigate Veteran Deaths!



Please be civil, agree to disagree, and express your opinion. Comments will be moderated for content to avoid inflammatory language and spam